of 2025, Abbott Laboratories performed well in the US medical device sector, with steady growth in its core product lines. According to leading data and analytics company GlobalData, some of Abbott’s high-volume product lines declined in average selling price (ASP) in the first six months of 2025,…
Continue reading...